Financials
- Market Capitalization 41.04 M
- Employee 17
- Founded 2009
- CEO N/A
- Website www.renovorx.com
- Headquarter Delaware, United States
- FIGI BBG005XWWZK6
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-2.63
ratio cours/chiffre d'affaires
26.43
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4374 | PDSB PDS Biotechnology Corporation - Common Stock | 0.75 USD | -2.60% | -11.76% | -30.56% | -38.52% | 41.86 M USD | ||
| 4382 | VERU Veru Inc. - Common Stock | 2.56 USD | -7.91% | -9.54% | -15.23% | +7.11% | 41.09 M USD | ||
| 4395 | GRCE Grace Therapeutics, Inc. - Common Stock | 2.43 USD | -0.82% | -4.33% | +10.45% | -38.94% | 39.55 M USD | ||
| 4398 | LTRN Lantern Pharma Inc. - Common Stock | 3.46 USD | -3.89% | -11.96% | -13.72% | -17.42% | 39.11 M USD |